During the past decade, McFarland Clinic PC-William R Bliss Cancer Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 52 clinical trials were completed, i.e. on average, 472.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 18 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "McFarland Clinic PC-William R Bliss Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Gynecologic Oncology Group" with 4 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "McFarland Clinic PC-William R Bliss Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "McFarland Clinic PC-William R Bliss Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Breast Cancer" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Recurrent Adult Brain Neoplasm" (3 trials) and "Recurrent Non-Small Cell Lung Carcinoma" (3 trials). Many other conditions were trialed in "McFarland Clinic PC-William R Bliss Cancer Center" in a lesser frequency.

Most popular intervention types in "McFarland Clinic PC-William R Bliss Cancer Center" are "Drug" (52 trials), "Other" (34 trials), "Biological" (21 trials), "Radiation" (8 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Bevacizumab" (8 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "McFarland Clinic PC-William R Bliss Cancer Center" are 44 trials for "All" genders, 13 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "McFarland Clinic PC-William R Bliss Cancer Center". undefined are not yet recruiting, undefined are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in McFarland Clinic PC-William R Bliss Cancer Center, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in McFarland Clinic PC-William R Bliss Cancer Center, 4 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".